Publications by authors named "Johannes D Schultz"

Claim this Profile
C
Clinical relevance of CYFRA 21-1 as a tumour marker in patients with oropharyngeal squamous cell carcinoma.
Stefan A Rudhart, Francesca Gehrt, Richard Birk, Johannes D Schultz, Petar Stankovic

Eur Arch Otorhinolaryngol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma?
Stefan A Rudhart, Johannes D Schultz, Francesca Gehrt, Friederike L Pavel, Richard Birk

Eur Arch Otorhinolaryngol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Small Molecules on β-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.
Benedikt Kramer, Clemens Hock, Johannes David Schultz, Anne Lammert, Beatrice Kuhlin

Anticancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.
Benedikt Kramer, Johannes David Schultz, Clemens Hock, Alexander Sauter, Boris A Stuck

Oncol Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro.
Benedikt Kramer, Clemens Hock, Richard Birk, Alexander Sauter, Boris A Stuck, Johannes David Schultz

Anticancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expression.
Claudia Umbreit, Philipp Erben, Anne Faber, Ralf-Dieter Hofheinz, Johannes David Schultz

Oncol Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome and Quality of Life After a Multimodal Therapy Approach to Ear Keloids.
Ute Walliczek, Stephan Engel, Christel Weiss, Christoph Aderhold, Christiane Lippert, Johannes David Schultz

JAMA Facial Plast Surg· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro.
Claudia Umbreit, Philipp Erben, Anne Faber, Ralf-Dieter Hofheinz, Christoph Aderhold, Johannes David Schultz

Anticancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of static magnetic fields combined with human insulin-like growth factor 1 on human satellite cell cultures.
Richard Birk, J Ulrich Sommer, Dominik Haas, Anne Faber, Christoph Aderhold, Johannes D Schultz

In Vivo· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC.
Christoph Aderhold, Anne Faber, Claudia Umbreit, Richard Birk, Christel Weiss, Johannes David Schultz

Anticancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapy.
Christoph Aderhold, Anne Faber, Claudia Umbreit, Anja Chakraborty, Andre Bockmayer, Johannes David Schultz

Anticancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Claudia Umbreit, Julia Flanjak, Christel Weiss, Philipp Erben, Christoph Aderhold, Johannes David Schultz

Anticancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study.
Christoph Aderhold, Guido Manuel Grobschmidt, Alexander Sauter, Anne Faber, Karl Hörmann, Johannes David Schultz

Oncol Lett· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.
Christoph Aderhold, Claudia Umbreit, Anne Faber, Richard Birk, Jörg Ulrich Sommer, Johannes David Schultz

Anticancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Claudia Umbreit, Christoph Aderhold, Anne Faber, Alexander Sauter, Ralf-Dieter Hofheinz, Johannes David Schultz

Oncol Rep· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional short- and long-term effects of nasal CPAP with and without humidification on the ciliary function of the nasal respiratory epithelium.
J Ulrich Sommer, Marius Kraus, Richard Birk, Johannes D Schultz, Karl Hörmann

Sleep Breath· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of a CD44+ head and neck squamous cell carcinoma cell line with a stromal cell-derived factor-1-expressing supportive niche: An model.
Anne Faber, Christoph Aderhold, Ulrich Reinhart Goessler, Karl Hoermann, Johannes David Schultz

Oncol Lett· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule-based chemotherapeutic approach in p16-positive and -negative HNSCC in vitro.
Christoph Aderhold, Anne Faber, Guido Manuel Grobschmidt, Anja Chakraborty, Andre Bockmayer, Johannes David Schultz

Anticancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma.
Anne Faber, Ulrich Reinhart Goessler, Karl Hoermann, Johannes David Schultz, Claudia Umbreit

Oncol Rep· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Claudia Umbreit, Christoph Aderhold, Anne Faber, Jörg Ulrich Sommer, Alexander Sauter, Johannes David Schultz

Anticancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Christoph Aderhold, Claudia Umbreit, Anne Faber, Alexander Sauter, Jörg Ulrich Sommer, Johannes David Schultz

Anticancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effects of doxycycline on inflammatory cytokines and gelatinases in chronic rhinosinusitis.
J Ulrich Sommer, Johannes D Schultz, Judith Grossbaier, Jens Stern-Straeter, Karl Hörmann

In Vivo· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 as a stem cell marker in head and neck squamous cell carcinoma.
Anne Faber, Christine Barth, Karl Hörmann, Stefan Kassner, Johannes David Schultz

Oncol Rep· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC.
Johannes D Schultz, Sarah Rotunno, Philipp Erben, J Ulrich Sommer, Clemens Anders

Oncol Rep· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis